Siemens Healthineers (OTCMKTS:SMMNY) Shares Down 2.3% – What’s Next?

Shares of Siemens Healthineers AG (OTCMKTS:SMMNY) were down 2.3% during trading on Wednesday. The company traded as low as $21.4025 and last traded at $21.44. 151,290 shares changed hands during mid-day trading, an increase of 9% from the average session volume of 139,052 shares. The stock had previously closed at $21.94.

Analyst Ratings Changes

Several research analysts recently weighed in on the stock. Deutsche Bank Aktiengesellschaft reissued a “hold” rating on shares of Siemens Healthineers in a research note on Tuesday, August 18th. Zacks Research upgraded shares of Siemens Healthineers from a “strong sell” rating to a “hold” rating in a report on Thursday, August 6th. Finally, Citigroup reissued a “buy” rating on shares of Siemens Healthineers in a research report on Thursday, August 27th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, Siemens Healthineers presently has a consensus rating of “Moderate Buy”.

Siemens Healthineers Trading Up 0.9%

The business’s fifty day moving average is $22.21 and its 200 day moving average is $21.05.

About Siemens Healthineers

Siemens Healthineers AG is a Germany-based medical technology company that develops and supplies products, services and digital solutions for healthcare providers. Its portfolio supports medical imaging, laboratory diagnostics, cancer treatment, minimally invasive procedures and related clinical workflows.

The company’s imaging business offers magnetic resonance imaging, computed tomography, molecular imaging, X-ray and ultrasound systems. Its diagnostics activities include laboratory testing, point-of-care testing and diagnostic IT solutions.